Skip to main content
SpringerLink
Log in

Virostatika in der Dermatologie

  • Chapter
Neue Entwicklungen in der Dermatologie

  • 12 Accesses

Zusammenfassung

Virostatica wie Idoxuridin, Vidarabin, Amantadin, Tromantadin, Äthyldesoxyuridin, Inosiplex, Acyclovir, Phosphonoformiat, Bromovinyldesoxyuridin und Fluordesoxyarabinofuranosyljodcytosin werden in bezug auf Angriffspunkte, Wirkmechanismen, bewiesene Wirkungen und Nebenwirkungen diskutiert. Die klinische Wirksamkeit und mögliche Indikationen werden besprochen. Auf Bedeutung und Zukunftsaspekte wird hingewiesen.

Summary

Antiviral drugs, e.g. Idoxuridine, Vidarabine, Amantadine, Tromantadine, Ethyldesoxyuridine, Inosiplex, Acyclovir, Phosphonoformiate, Bromovinyldesoxyuridine and Fluordeoxyarabinofuranosyljodcyto- sin are discussed in respect to working points, mechanisms of action, prooven effects and side effects. Clinical efficacy and possible indications are referred. Significance and futur aspects are pointed out.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Abeles, J H.: Inosiplex in recurrent herpes simplex infections. Lancet 23, 926, (1982).

    Article  Google Scholar 

  2. Ahumada, P M.: Zur Wirksamkeit von Tromantadin bei Herpes simplex. Doppelblindstudie. Ther. Gegenw. 116, 100–108 (1977).

    CAS  Google Scholar 

  3. AI Nakib, W, AI Kandari, S, El Khalik, D M A, El Shirbiny, A M.: A randomised controlled study of intravenous Acyclovir (Zovirax) against placebo in adults with chickenpox. J. Infect. 6, Suppl 1, 49–56 (1983).

    Google Scholar 

  4. Balfour, H H jr, Bean, B, Laskin, O L, Ambinder, R F, Meyers, J D, Wade J C.: Acyclovir halts progression of herpes zoster in immunocompromised patients. New Engl. J. Med. 308, 1448–1453 (1983).

    Article  PubMed  Google Scholar 

  5. Becker, A.: TK-gene and HSV-resistance. Int. Symp. antiviral compounds and wound healing Hamburg 14. 16. June (1983).

    Google Scholar 

  6. Borelli, S, Gehrken, H.: Therapeutische Erfahrungen bei Herpes simplex-Erkrankungen mit Tromantadin-HCl im Doppelblindversuch. Schweiz. Rdsch. Med. (Praxis) 65, 108–110 (1976).

    CAS  Google Scholar 

  7. Brigden, S, Whiteman, P.: The mechanism of action, pharmacokinetics and toxicity of Acyclovir - a review. J. Infect. 6, Suppl 1, 3–9 (1983).

    Google Scholar 

  8. Bryson, Y J, Dillon, M, Lovett, M, Acuna, G, Taylor, S, Cherry, J D.: Treatment of first episodes of genital herpes simplex virus infection with oral Acyclovir. A randomized double-blind controlled trial in normal subjects. New Eng. J. Med. 308, 916–921 (1983).

    Article  CAS  PubMed  Google Scholar 

  9. Bunta, S, Peris, Z.; Immunstimulierende Zostertherapie (Dreijährige Erfahrungen mit Inosiplex). Z. Hautkr. 56 (22), 1457–1466 (1982).

    Google Scholar 

  10. Cheng, Y, Nakayama, K, Derse, D, Bastow, K, Ruth, J, Tan, R, Dutschmann, G, Caradonna, S J, Grill, S.: Herpes virus specific enzymes: properties, physiological roles, and pharmacological implications. In: Herpesvirus. Clinical, pharmacological and basic aspects. Proc. Int. Congr. Ser. Exeerpta Medica 47–56 (1982).

    Google Scholar 

  11. Chilf G N, Runne, U.: Intravenöse Zoster-Behandlung mit Acyclovir bei Patienten mit malignen Systemkrankheiten. Hautarzt 34, Suppl. VI, 336–337 (1983).

    Google Scholar 

  12. de Clercq, E, Zhang, Z X, Sim, I S.: Treat-ment of experimental herpes virus encephalitis with (E)-5-(2-bromovinyl)-2’-deoxyuridine in mice. Antimicrob. Agents Chemother. 22, 421–425 (1982).

    PubMed  Google Scholar 

  13. Corey, L, Benedetti, J, Critchlow, C, Mertz, G, Douglas, J, Fife, K, Fahnlander, A, Remington, M L, Winter, C, Dragavon, J.: Treatment of primary firstepisode genital herpes simplex virus infections with acyclovir: results of topical, intravenous and oral therapy. J. antimicrob. Chemother. 12, Suppl B, 79–88.(1983).

    PubMed  Google Scholar 

  14. Corey, L, Fife, K H, Benedetti, J K, Winter, CA, Fahnlander, A, Connor, J D.: Intravenous acyclovir for the treatment of primary genital herpes. Ann. intern. Med. 98, 914–921 (1982).

    Google Scholar 

  15. Corey, L, Holmes, K K, Benedetti, J, Critchlow, C.; Clinical course of genital herpes. In: Nahmias, A J, Dowdle, W R, Schinazi, R F. eds. The human herpes viruses: an interdisciplinary perspective. Elsevier New York pp 496–502.(1981).

    Google Scholar 

  16. Crane, L R, Sunstrum, J C, Lerner, A M.: Combination therapy of experimental infection with herpes simplex virus, type 2. Clin. Res. 31, 541 A (1983).

    Google Scholar 

  17. Crumpacker, C S, Schnipper, L E, Kowalsky, P N, Sherman, D M.: Resistance of herpes simplex virus to adenine arabinoside and E-5-(2-bromovinyl)2’-deoxyuridine: A physical analysis. J. infect. Dis. 146, 167–172 (1982).

    Article  CAS  PubMed  Google Scholar 

  18. Crumpacker, C S, Schnipper, L E, Marlowe, S T, Kowalsky, P N, Hershey, B J, Levin, M J.: Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir (1982).

    Google Scholar 

  19. Daksis, JI, Priemer, M M, Chan, V L.: Isolation and preliminary characterization of a phosphonoacetic acid-resistant and temperature-sensitive mutant of herpes simplex virus type 1. J. Virol. 42, 20–29 (1982).

    CAS  PubMed  Google Scholar 

  20. Dawber, R P R.: Idoxuridine in herpes zoster. Further evaluation of intermittent topical therapy. Brit. med. J. 2, 526–529 (1974).

    Article  CAS  PubMed  Google Scholar 

  21. Field, H J.: Drug resistance in herpes simplex virus. In: Herpesvirus. Clinical, pharmacological and basic aspects. Proc. Int. Congr. Ser. Experta Medica 205–210.(1982).

    Google Scholar 

  22. Fiddian, A P, Yeo, J M, Stubbings, R, Dean, D.: Successful treatment of herpes labialis with topical acyclovir. Brit. med. J. 286, 1699–1701 (1983).

    Article  CAS  Google Scholar 

  23. Galbraith, A W: Prevention of postherpetic neuralgia by amantadine hydrochloride (Symmetrel). Brit. J. clin. Pract. 37, 304–306 (1983).

    CAS  PubMed  Google Scholar 

  24. Galli, M, Lazzarin, A, Moroni, M, Zanussi, C: Inosiplex in recurrent herpes simplex infections. Lancet II, 331–332.(1982).

    Article  Google Scholar 

  25. Gauri, K K, Wassilew, S W: Chemotherapie bei Virus-Erkrankungen. Offizin. Pharm. 26–42 (1983).

    Google Scholar 

  26. Gluckmann, E, Devergie, A, Melo, R, Nebout, T, Lotsberg, J, Zhao, X M.: Prophylaxis of herpes infections after bone -marrow transplantation by oral acyclovir. Lancett II, 706–708 (1983).

    Google Scholar 

  27. Gould, J M, Chessells, J M, Marshall, W C, Mendrick, G D W: Acyclovir in herpesvirus infections in children: Experience in an open study with particular reference to safety. J. Infect. 5, 283 -289.(1982).

    Article  Google Scholar 

  28. Hann, IM, Prentice, H G, Blacklock, H A, Ross, M G R, Brigden, D, Rosling, A E.: Acyclovir prophylaxis against herpes virus infections in severely immuncompromised patients: Randomised double blind trial. Brit. med. J. 287, 384–388 (1983).

    CAS  Google Scholar 

  29. Heidemann, E, Wilms, K, Treuner, J, Niethammer, D.: Fibroblasten-Interferon zur Behandlung des Herpes zoster. Eine Pilotstudie. Dtsch. med. Wschr. 107, 695–697 (1982).

    Article  CAS  Google Scholar 

  30. Hellgren, L, Herrmann, L S.: Tromantadine hydrochloride in the treatment of herpes simplex. Dermato-lógica (Basel) 167, 267–272 (1983).

    Article  CAS  Google Scholar 

  31. Hofschneider, P H, Obert, HJ.: Vorläufige klinische Erfahrungen mit humanem Fibroblasteninterferon in der Bundesrepublik Deutschland. Verh. Dtsch. Ges. inn. Med. 507- 512.(1982).

    Google Scholar 

  32. Janz, C, Wigand, R.: Combined interaction of antiherpes substances and Interferon beta on the multiplication of herpes simplex virus. Arch. Virol. 73, 135–143 (1982).

    Article  CAS  PubMed  Google Scholar 

  33. Juel-Jensen, B E, Khan, J A, Pasvol, G.: Highdose intravenous acyclovir in the treatment of zoster: A doubleblind placebo-controlled trial. J. Infect. 6, Suppl 1, 31–36 (1983).

    Google Scholar 

  34. Kaufman, E.: New understanding of ocular herpetic disease. Amer. J. Ophthal. 94, 119–121 (1982).

    CAS  PubMed  Google Scholar 

  35. Krasny, H C, Liao, S H T, Good, S S.: Oral pharmacokinetics and metabolism of the prodrug of acyclovir. A134U, in humans. Clin. Pharmacol. Ther. 33, 256 (1983).

    Google Scholar 

  36. Kumor, K M, Woo, J, Conklin, R.: Renal function in immunocompromised patients receiving acyclovir for herpes virus infections. Clin. Res. 30, 253 A (1982).

    Google Scholar 

  37. Larkin, M, Ogilvie, M, Mill, J I.: Effect of low dose acyclovir (5 mg/kg) on virus shedding, interferon and humoral immunity in herpes zoster. J. antimicrob. Chemother. 12, 79–87 (1983).

    Article  CAS  PubMed  Google Scholar 

  38. Leyland, J B, Donnelly, H, Myskowski, P, Donner, A, Groshen, S, Lopez, C.: FIAC, a potent new antiviral agent: Therapeutic superiority over adenine arabinoside (ARA-A) against varicella zoster infections in immunosuppressend patients. Clin. Res. 31, 369A (1983).

    Google Scholar 

  39. Leyland, J B, Feinberg, A, Vidal, P, Fanucchi, M, Williams, L, Young, C.: Human metabolism of 24-fluoro-5-jodo-l beta-D-arabinosylcytosine (FIAC). Proc. Amer. Ass. Cancer Res. 24, 136 (1983).

    Google Scholar 

  40. Madgal, P C, Uyttebroeck, W, de Clercq, E, Missotten, L.: Oral and topical treatment of experimental herpes simplex iritis with bromovinyldeoxyuridine. Arch. Ophthal. (Chicago) 100, 1337–1340 (1982).

    Google Scholar 

  41. Mill, J, Maonald, D R, Fall, C, Donald, G, Mendrick, W, Copplestone, A.: Intravenous acyclovir in acute herpes zoster infection. J. Infect. 6, 157–151 (1983).

    Article  Google Scholar 

  42. Mindel, A, Sutherland, S.: Genital herpes - the disease and this treatment in-cluding intravenous acyclovir. J. antimicrob. Chemother. 12, Suppl. B, 51- 59.(1983).

    PubMed  Google Scholar 

  43. Nasemann, Th.: Viruskrankheiten der Haut, der Schleimhäute und des Genitale. Thieme Stuttgart (1974).

    Google Scholar 

  44. Oberg, B.: Antiviral effects of phosphonoformiate (PFA, Foscarnet Sodium). Pharmacol. Ther. 10, 387–415 (1983).

    Google Scholar 

  45. Orenstein, WA.: Prophylaxis of varicella in high-risk children: Doseresponse effect of zoster immune globulin. J. Pediat. (St. Louis) 98, 368–373 (1981).

    CAS  Google Scholar 

  46. Peterslund, NA, Black, F T, Tauris, P.: Impaired renal function after injections of acyclovir. Lancet I, 243–244 (1983).

    Google Scholar 

  47. Preiksaitis, J K, Rosno, S, Grumet, C, Merigan, T C.: Infections due to herpesviruses in cardiac transplant recipients: Role of the donor heart and immunosuppressive therapy. J. infect. Dis. 147, 974–981. (1983).

    Article  CAS  PubMed  Google Scholar 

  48. Prentice, H G, Hann, I M.: Prophylactic studies against herpes infections in severely immunocompromised patients with acyclovir. J. Infect. 6, Suppl. 1, 17–21 (1983).

    Google Scholar 

  49. Prober, C G, Kirk, L E, Keeney, R E.: Acyclovir therapy of chickenpox in immunsuppressed children: A collaborative study. J. Pediat. (St. Louis) 101, 622- 625.(1982).

    CAS  Google Scholar 

  50. Raab, B, Lorincz, A L.: Topical acyclovir caution. J. Amer. Acad. Derm. 124 (1983).

    Google Scholar 

  51. Reichman, R C, Badger, G J, Guinan, M E, Nahmias, A J, Keeney, R E, Davis, L G.: Topically administered acyclovir in the treatment of recurrent herpes simplex genitalis: A controlled trial. J. infect. Dis. 147, 336–340 (1983).

    Article  CAS  PubMed  Google Scholar 

  52. Reichman, R C, Badger, G J, Mertz, G J, Corey, L, Richman, D, Oxman, M.: Patient-initiated therapy of recurrent herpes simplex genitalis with orally administered acyclovir. Clin. Res. 31, 373A (1983).

    Google Scholar 

  53. Rosenthal, K S, Sokol, M S, Ingram, R L, Subramanian, R, Fort, R C: Tromantadine: Inhibitor of early and late events in herpes simplex virus replication. Antimicrob. Agents Chemother. 22, 1031–1136 (1982).

    CAS  PubMed  Google Scholar 

  54. Schneider, W, Schneider, B.: Wirkungen und Nebenwirkungen der topischen Therapie bei Herpes simplex-Infektionen der Haut. Therapiewoche 32, 5352–5358 (1982).

    Google Scholar 

  55. Schoeßnius, H H.: Moderne Therapie des Herpes simplex. Med. Klin. 78, 91–94 (1983).

    Google Scholar 

  56. Shigeta, S, Yokota, T, Iwabuchi, T, Baba, M, Konno, K, Ogata, M.: Comparative efficacy of antiherpes drugs against various strains of varicella zoster virus. J. infect. Dis. 147, 576–584 (1983).

    Article  CAS  PubMed  Google Scholar 

  57. Sibrack, C D, Gutman, L T, Wilfert, C M, Maren, C, Glair, M G St, Keller, P M.: Pathogenicity of acyclovir-resistant herpes simplex virus type 1 from an immunodeficient child. J. infect. Dis. 146, 673–682 (1982).

    Article  CAS  PubMed  Google Scholar 

  58. Silvestri, D L, Corey, L, Holmes, K K: Ineffectivness of topical idoxuridine in dimethylsulfoxide for therapy for genital herpes. JAMA 248, 953–959 (1982).

    Article  CAS  PubMed  Google Scholar 

  59. Steele, R W, Keeney, R E, Bradsher, R W, Moses, E B, Soloff, B L.: Treatment of varicellazoster meningoencephalitis with acyclovir-demonstration of virus in cerebrospinal fluid by electron microscopy. Amer. J. clin. Path. 80, 57–60 (1983).

    CAS  Google Scholar 

  60. Stiehm, E R, Kronenberg, L H, Rosenblatt, H M, Bryson, Y, Merigan, TC.: Interferon: Immunobiology and clinical significance. Ann. intern. Med. 96, 80–93 (1982).

    CAS  PubMed  Google Scholar 

  61. Straus, S, Seidlin, M, Takiff, H, Bachrach, S, Di Giovanna, J, Western, K: Suppression of recurrent genital herpes with oral acyclovir. Clin. Res. 31, 543A (1983).

    Google Scholar 

  62. Swart, R N J, Vermeer, B J, Meer, J W M van der, Enschede, F A J, Versteeg, J.: Treatment of eczema herpeticum with acyclovir. Arch. Derm. 119, 13–16 (1983).

    Article  CAS  PubMed  Google Scholar 

  63. Teh, C Z, Sacks, S L.: Susceptibility of recent clinical isolates of herpes simplex virus to 5-ethyl-2/-deoxyuridine: Preferential inhibition of herpes simplex virus type 2. Antimicrob. Agents Chemother. 23, 637–640 (1983).

    CAS  PubMed  Google Scholar 

  64. Theml, H, Siegert, W, Ziegler, H W L, Huhn, D.: Interferon, eine der interessantesten biologischen Substanzen, aber kein Allheilmittel. Med. Klin. 77, 132–139 (1982).

    Google Scholar 

  65. Thin, R N, Nabarro, J M, Parker, J D, Fiddian, A P.: Topical acyclovir in the treatment of initial genital herpes. Brit. J. vener. Dis. 59, 116–119 (1983).

    CAS  Google Scholar 

  66. Walle, van der H B, Malten, K E, Wargemakers, T H.: Contactallergie voor tromantadine (Viru Merz) bij de Behandeling van Herpes simplex infecties. Ned. T. Geneesk. 126, 1033–1035 (1982).

    PubMed  Google Scholar 

  67. Wallin, J, Lernestedt, L O, Lycke, E.: Treatment of recurrent herpes labialis with trisodium phosphonoformiate. Antivirals 8, 1361–1363 (1979).

    Google Scholar 

  68. Wassilew, S W.: Acyclovir (Zovirax®). Arzneimittelther 1. Jahrg, 4 (1983).

    Google Scholar 

  69. Wassilew, S W.: Möglichkeiten und Grenzen der Chemotherapie bei Erkrankungen durch das Herpes simplex- und das Varicella-Zoster-Virus. Hautarzt 24, 1–5 (1983).

    Google Scholar 

  70. Whitley, R J, Soong, S J, Hirsch, M S, Karchmer, A W, Dolin, R, Calasso, G, Dunnick, J K, Alford, CA.: Herpes simplex encephalitis. Vidarabine therapy and diagnostic problems. New Engl. J. Med. 304, 313–318 (1981).

    CAS  Google Scholar 

  71. Whitley, R J, Ch’ien, L T, Dolin, R, Galasso, G, Alford, CA, and editors of the Collaborative Study Group.: Adenine arabinoside therapy of herpes zoster in the immunosuppressed: NIAID collaborative antiviral study. New Engl. J. Med. 294, 1193–1199 (1976).

    CAS  Google Scholar 

  72. Whitley, R J, and the NIAID Collaborative Antiviral Study Group: Interim summary of mortality in herpes simplex encephalitis and neonatal herpes simplex virus infections: vidarabine versus acyclovir. J. antimicrob. Chemother. 12, Suppl. B, 105–112 (1983).

    Google Scholar 

  73. Wildenhoff, K E, Esmann, V, Ipsen, J, Harving, H, Peterslund, N A, Schonhey der, H.: Treatment of trigeminal and thoracic zoster with idoxuridine. Scand. J. infect. Dis. 13, 251–262.(1981).

    Google Scholar 

  74. Yeo, J M, Fiddian, A P.: Acyclovir in the management of herpes.labialis. J. antimicrob. Chemother. 12, Suppl. B, 95–103 (1983).

    PubMed  Google Scholar 

  75. Yokota, T, Shigeta, S, Iwabuchi, T, Ogata, M, Takami, Z.: Mutant strain of varicella zoster virus deficient in thymidine kinase- inducing activity. In: Herpesvirus. Clinical pharmacological and basic aspects. Proc. Excerpta Medica Int. Congr. Ser. pp 102–105 (1982).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitäts-Hautklinik Hamburg, Martinistr. 52, D-2000, Hamburg 20, Deutschland

    S. W. Wassilew & Prof. Dr. Th. Nasemann (Direktor)

Authors
  1. S. W. Wassilew
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. Th. Nasemann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Erlangen, Deutschland

    O. P. Hornstein

  2. Münster-Hornheide, Deutschland

    M. Hundeiker

  3. Mannheim, Deutschland

    J. Schönfeld

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Wassilew, S.W., Nasemann, T. (1987). Virostatika in der Dermatologie. In: Hornstein, O.P., Hundeiker, M., Schönfeld, J. (eds) Neue Entwicklungen in der Dermatologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73248-5_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-73248-5_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-18636-6

  • Online ISBN: 978-3-642-73248-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation